Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Cash from Operations (2020 - 2025)

Treace Medical Concepts (TMCI) has disclosed Cash from Operations for 6 consecutive years, with 8026000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Operations fell 90.78% year-over-year to 8026000.0, compared with a TTM value of 15970000.0 through Dec 2025, up 57.03%, and an annual FY2025 reading of 15970000.0, up 57.03% over the prior year.
  • Cash from Operations was 8026000.0 for Q4 2025 at Treace Medical Concepts, up from 9092000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 4198000.0 in Q1 2025 and bottomed at 17259000.0 in Q1 2023.
  • Average Cash from Operations over 5 years is 6777650.0, with a median of 7352000.0 recorded in 2022.
  • The sharpest move saw Cash from Operations crashed 1514.35% in 2022, then soared 158.14% in 2025.
  • Year by year, Cash from Operations stood at 3752000.0 in 2021, then plummeted by 42.8% to 5358000.0 in 2022, then surged by 109.93% to 532000.0 in 2023, then tumbled by 890.79% to 4207000.0 in 2024, then tumbled by 90.78% to 8026000.0 in 2025.
  • Business Quant data shows Cash from Operations for TMCI at 8026000.0 in Q4 2025, 9092000.0 in Q3 2025, and 3050000.0 in Q2 2025.